Of note, deep sequencing of TRM in human lung cancer has revealed that TRM appears to be functionally exhausted to varying degrees, expressing multiple immune checkpoints, especially PD-1 and Tim-3, which suggests that TRM cells are highly heterogeneous and may be a potential target of immune checkpoint blockade [8, 13, 14]. The gene discussed is HAVCR2; the disease is lung cancer.